Cerity Partners LLC trimmed its position in Hawkins, Inc. (NASDAQ:HWKN - Free Report) by 6.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 76,884 shares of the specialty chemicals company's stock after selling 5,692 shares during the quarter. Cerity Partners LLC owned about 0.37% of Hawkins worth $8,144,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the stock. Proficio Capital Partners LLC purchased a new stake in shares of Hawkins in the fourth quarter valued at about $2,984,000. Raymond James Financial Inc. acquired a new stake in Hawkins in the fourth quarter valued at $13,087,000. Amundi acquired a new stake in shares of Hawkins during the fourth quarter worth about $271,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Hawkins by 14.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,403 shares of the specialty chemicals company's stock worth $785,000 after buying an additional 798 shares during the period. Finally, Commonwealth Equity Services LLC increased its stake in Hawkins by 118.1% in the 4th quarter. Commonwealth Equity Services LLC now owns 5,603 shares of the specialty chemicals company's stock valued at $687,000 after buying an additional 3,034 shares during the period. 69.71% of the stock is currently owned by hedge funds and other institutional investors.
Hawkins Price Performance
Shares of HWKN traded down $2.21 on Friday, hitting $161.38. The company's stock had a trading volume of 141,706 shares, compared to its average volume of 133,856. The company has a market capitalization of $3.37 billion, a PE ratio of 39.95, a PEG ratio of 2.73 and a beta of 0.85. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.15 and a quick ratio of 1.37. The company has a 50 day moving average price of $138.94 and a 200 day moving average price of $121.63. Hawkins, Inc. has a fifty-two week low of $98.30 and a fifty-two week high of $165.87.
Hawkins (NASDAQ:HWKN - Get Free Report) last released its earnings results on Wednesday, May 14th. The specialty chemicals company reported $0.78 EPS for the quarter, topping analysts' consensus estimates of $0.74 by $0.04. Hawkins had a net margin of 8.66% and a return on equity of 18.93%. The firm had revenue of $245.32 million during the quarter, compared to analyst estimates of $230.69 million. On average, research analysts anticipate that Hawkins, Inc. will post 4 earnings per share for the current fiscal year.
Hawkins Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, June 13th. Stockholders of record on Friday, May 30th were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.45%. The ex-dividend date was Friday, May 30th. Hawkins's dividend payout ratio (DPR) is presently 17.82%.
Wall Street Analyst Weigh In
HWKN has been the topic of a number of analyst reports. Wall Street Zen lowered shares of Hawkins from a "buy" rating to a "hold" rating in a research note on Saturday, July 5th. BWS Financial reaffirmed a "buy" rating and set a $160.00 target price on shares of Hawkins in a research note on Thursday, May 15th. Finally, CJS Securities assumed coverage on shares of Hawkins in a research note on Tuesday, April 1st. They issued a "market outperform" rating and a $125.00 price objective for the company.
Get Our Latest Report on HWKN
Hawkins Profile
(
Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Featured Stories

Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.